Technical analysis of PTC Therapeutics, Inc. (PTCT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications.
Price Performance
| 1 month | -6.83% |
| 3 months | -14.32% |
| Year-to-date | -10.91% |
| 1 year | +11.57% |
| 3 years | +178.71% |
52-Week Range
| 52-week High | $90.87 |
| 52-week Low | $57.74 |
| Avg Volume (90d) | 1.5M |
Technical Indicators
| SMA 50 | $73.06 |
| SMA 200 | $72.82 |
| Beta | 0.55 |
| 30-day Volatility (annualised) | 29.8% |
| Price vs SMA 50 | -7.4% |
| Price vs SMA 200 | -7.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $68.31 | |
| 2025-11 | $85.99 | +25.9% |
| 2025-12 | $75.96 | -11.7% |
| 2026-01 | $75.53 | -0.6% |
| 2026-02 | $68.19 | -9.7% |
| 2026-03 | $68.13 | -0.1% |
| 2026-04 | $65.06 | -4.5% |
| 2026-05 | $73.85 | +13.5% |
| 2026-06 | $81.57 | +10.5% |
| 2026-07 | $68.01 | -16.6% |
| 2026-08 | $69.54 | +2.2% |
| 2026-09 | $67.67 | -2.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | $0.06 | $67M |
| 2026-09-15 | | |
| 2026-09-15 | | $149M |
| 2026-09-15 | | |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | | |
Price
| Price | $67.35 |
| Market Cap | $5.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -33.74 |
| EV / EBITDA | 30.47 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -4.21 |
| Current Ratio | 3.39 |